⚕ GalenOps CRO console
← 714 (USA)

714-1375

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 714 (USA) (Dr. Clarke) · consented 2013-02-26
Adverse events
8
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Mild EAR PAIN — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-04-04 (study day 38.0); relationship: NONE

mild assessed 2026-08-18

Mild EAR PAIN — outcome: RECOVERED/RESOLVED; onset 2013-04-04 (study day 38.0); relationship: NONE

moderate assessed 2026-08-18

Moderate ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-16 (study day 111.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-16 (study day 111.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-29 (study day 93.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-29 (study day 93.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate SKIN IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-30 (study day 33.0); relationship: NONE

moderate assessed 2026-08-18

Moderate SKIN IRRITATION — outcome: RECOVERED/RESOLVED; onset 2013-03-30 (study day 33.0); relationship: NONE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.